A NEWTOWN-based manufacturer which aids in cancer diagnostics has secured an agreement with a US-based medical company to become its exclusive distributor in the UK. CellPath, a manufacturer and worldwide supplier of products, consumables, and services related to cancer diagnostics, has signed the agreement with Biocare Medical LLC. Biocare is a major US innovator, becoming the market leader in the development of simultaneous multiplex immunohistochemistry tests that provide increased confidence at critical diagnostic decision points, positively impacting patient therapy while accelerating turnaround time. The agreement will take effect from June 1 and should bring significant growth and job expansion to CellPath.
Engineer who innovated in soft drinks dies
royalgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from royalgazette.com Daily Mail and Mail on Sunday newspapers.
Ebertlang und Hornetsecurity werden Partner
it-business.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from it-business.de Daily Mail and Mail on Sunday newspapers.
PolyPeptide Group plans IPO and listing on the Swiss Stock Exchange
EQS Group-News: PolyPeptide Group / Key word(s): IPO
12.04.2021 / 07:00
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
FOR RELEASE IN SWITZERLAND - THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGENDS CONTAINED HEREIN.
PolyPeptide Group plans IPO and listing on the Swiss Stock Exchange